N J L M

 
Subscribe Via RSS
  • Home
  • About
    Salient Features Bibliographic Information Abstracting and Indexing Specialties Covered Publisher Journal Policy
  • Issues
    Current Issue Online Ahead of Print Archive Forthcoming issue
  • Editorial
    Editorial Statements Editorial-PeerReview Process Editorial Board Publication Ethics & Malpractice Join us
  • Authors
    Submit an Article Manuscript Instructions Manuscript Assistance Publication Charges Paid Services Early Online Publication Service
  • Reviewers
    Apply as Reviewer Reviewers Acknowledgment
  • Search
    Simple Search Advanced Search
  • Member
    Register Login
  • Contact
  • Subscription
Original article / research
Year: 2014 Month: September Volume: 3 Issue: 3 Page: 1 - 4

Diagnostic utility of Anti-cyclic Citrullinated Peptide Antibodies for Very Early Rheumatoid Arthritis

 
Correspondence Sucilathangam G, Anna T, Velvizhi G,
Dr. G. Sucila Thangam,
Senior Assistant Professor, Department of Microbiology,
Tirunelveli Medical College, Palayamkottai-627011,
Tirunelveli Dt., Tamil Nadu, India.
Phone : 9442063819
E-mail : drgsucila@rediffmail.com
:
Background and Objectives: Rheumatoid arthritis (RA) is a systemic autoimmune disorder characterized by widespread joint inflammation with synovial hyperplasia. The most well known diagnostic marker is rheumatoid factor (RF).However; RF is not a good marker for RA, because it can be detected in autoimmune disorders other than RA as well as in 3-5% of healthy individuals. Recent studies indicated that Anti-CCP testing is particularly useful in the diagnosis of RA with high specificity present early in the disease process. Therefore, we aimed in our study to evaluate the diagnostic performances of anti-cyclic Citrullinated peptides antibody (anti-CCP) ELISA and Rheumatoid Factor in a group of patients with RA and non RA patients in Tirunelveli.

Materials and Methods: This prospective study, which was carried out for a period of six months in a tertiary care hospital. Blood was collected with informed consent in 65 RA patients and 30 non RA patients and serum was subjected to Rheumatoid Factor latex kit (AGAPPE Diagnostics, Kerala) and anti-CCP antibody detection by Enzyme Linked Immunosorbent assay (Euroimmun, Germany) with the cut-off at 8 IU/ml and 5 RU/ml respectively. The cut-off values recommended by the respective manufacturers were used to determine the sensitivity and specificity.

Results: This study shows that Sensitivity of anti-CCP was 58.3% with better specificity (100%) in RA patients whereas Sensitivity of anti-CCP was 50% with specificity (89.3%) in non RA patients. The combination of Rheumatoid factor (RF) and antibodies against cyclic Citrullinated provide better specificity to anti-CCP assay.

Conclusion: Anti-CCP assay could be a useful serological test for the diagnosis of patients with early stages of RA, because anti-CCP revealed higher diagnostic specificity than RF. The high specificity of anti-CCP antibodies is particularly useful in RF-negative RA patients. Anti-CCP antibodies are more specific than RF for diagnosing rheumatoid arthritis. In Sudanese patients with RA, anti-CCP antibodies exhibit a better diagnostic value than RF.
 
[ FULL TEXT ]   |   [ ]
 
Print
  • Article Utilities

    • Readers Comments (0)
    • Article in PDF
    • Citation Manager
    • Article Statistics
    • Link to PUBMED
    • Print this Article
    • Send to a Friend
    • Go To Issues

      • Current Issue
      • Past Issues
  • Search Articles

    • Simple Search
    • Advance Search
  • Authors Facilities

    • Extensive Author Support
    • Submit Manuscript
    • ONLINE First Facility
    • NJLM Pre Publishing
  • Quick Links

    • REVIEWER
    • ACCESS STATISTICS
  • Users

    • Register
    • Log in
  • Pages

    • About
    • Issues
    • Editorials
    • Authors
    • Reviewers
    • Search
    • Contacts
  • Issues Archives

  • Affiliated Websites

    • JCDR Prepublishing
    • Neonatal Database Home
    • JCDR Neonatal Database download center